Advertisement

Topics

Latest "Florida Institute for the Commercialization of Public Research" News Stories

19:18 EST 15th January 2019 | BioPortfolio

Here are the most relevant search results for "Florida Institute for the Commercialization of Public Research" found in our extensive news archives from over 250 global news sources.

More Information about Florida Institute for the Commercialization of Public Research on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Florida Institute for the Commercialization of Public Research for you to read. Along with our medical data and news we also list Florida Institute for the Commercialization of Public Research Clinical Trials, which are updated daily. BioPortfolio also has a large database of Florida Institute for the Commercialization of Public Research Companies for you to search.

Showing "Florida Institute Commercialization Public Research" News Articles 1–25 of 37,000+

Tuesday 15th January 2019

Ventas Announces Treatment of 2018 Distributions

Ventas, Inc. (NYSE: VTR) announced today the tax treatment of its 2018 distributions. The Company’s dividends for 2018 totaled $3.1625 per share, taking into account its first through fourth quarter 2018 dividends whose ex-dividend dates all occurred in 2018. For income tax purposes, total taxable dividend income for 2018 was $3....


Lianluo Smart Expands Its Sleep Diagnostic Offering Into More Than Forty Major Public Hospitals in China

BEIJING, Jan. 15, 2019 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (Nasdaq: LLIT), a China based professional smart service and products provider today announced its wearable sleep diagnostic product and cloud-based service from the Company's wholly owned subsidiary, Lianluo Connection Medical Wearable Device Technology...

Scientists Connect Dots Between Colitis, Colon Cancer

NewsLingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report one way it resets the stage to enable this common and often deadly cancer.


Revance Announces Proposed Public Offering of Common Stock

Revance Therapeutics, Inc. (Nasdaq:RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions (“Revance” or the “Company”), today announced a proposed underwritten public offering in which it will issue and sell approximately $100 million of shares of its common stock. Revance ...

$FPRX Restructuring to Focus on Clinical Development and Later-Stage Research Priorities https://www.businesswire.com/news/home/20190115005847/en/Prime-Announces-Restructuring-Focus-Clinical-Development-Later-Stage …

$FPRX Restructuring to Focus on Clinical Development and Later-Stage Research Priorities https://www.businesswire.com/news/home/20190115005847/en/Prime-Announces-Restructuring-Focus-Clinical-Development-Later-Stage …

Illumina to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Tuesday, January 29, 2019

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2018 following the close of market on Tuesday, January 29, 2019. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial ...

Five Prime Announces Restructuring to Focus on Clinical Development and Later-Stage Research Priorities

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced today a corporate restructuring to focus resources on its development pipeline, comprising five clinical-stage cancer program

New Materials Could Help Improve the Performance of Perovskite Solar Cells

NewsNew research could lead to the design of new materials to help improve the performance of perovskite solar cells (PSCs). Contributed Author:

Dayton Children's Hospital, Nationwide Children's Hospital Join in Cancer and Blood Disorders Collaborative

Dayton Children’s Hospital and Nationwide Children’s Hospital have announced a cancer, blood disorder and bone marrow transplant collaborative that will enhance services, create more research opportunities for both institutions and allow more patients from the Dayton region to stay closer to home during treatment. DAYTON, Ohio (PRWEB) January 15, 2019 Dayton Children’s Hospital and Nationwi...

TerraNet (158355634TERRNT) - Termination of coverage

Edison Investment Research - Technology - TerraNet: Edison Investment Research is terminating coverage on TerraNet (TERRNT). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: SE0009806045

QEX Logistics (QEX) - Termination of coverage

Edison Investment Research - Industrial Support Services - QEX Logistics : Edison Investment Research is terminating coverage on QEX Logistics (QEX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: NZQEXE0001S5

G3 Exploration (G3E) - Termination of coverage

Edison Investment Research - Oil & gas - G3 Exploration : Edison Investment Research is terminating coverage on G3 Exploration (G3E). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: KYG409381053

Foresight Autonomous Holdings (158355634FRSX) - Termination of coverage

Edison Investment Research - Technology - Foresight Autonomous Holdings: Edison Investment Research is terminating coverage on Foresight Autonomous Holdings (FRSX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: IL0001990188

Pointer Telocation (158355634PNTR) - Termination of coverage

Edison Investment Research - Technology - Pointer Telocation : Edison Investment Research is terminating coverage on Pointer Telocation (PNTR). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: IL0010826274

Leigh Creek Energy (LCK) - Termination of coverage

Edison Investment Research - Oil & gas - Leigh Creek Energy: Edison Investment Research is terminating coverage on Leigh Creek Energy (LCK). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: AU000000LCK5

Volt Resources (VRC) - Termination of coverage

Edison Investment Research - Mining - Volt Resources : Edison Investment Research is terminating coverage on Volt Resources (VRC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: AU000000VRC9

Lazard World Trust Fund (WTR) - Termination of coverage

Edison Investment Research - Investment Companies - Lazard World Trust Fund: Edison Investment Research is terminating coverage on Lazard World Trust Fund (WTR). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: LU0483266259

VC Funding for Digital Health Reaches $9.5 Billion in 2018, up 32 Percent YoY

Mercom Capital Group, a global communications and research firm, released its annual report on funding and mergers and acquisitions (M&A) activity in Digital Health / Healthcare Information Technology for 2018. Mercom’s comprehensive report covers deals of all sizes from around the world. Full Report Global venture cap...

Jonathan Berent Announces First of Its Kind Library of Clinical Interviews on Public Speaking and Fear of Being Noticeably Nervous

Millions Experience Public Speaking Anxiety In the Form of Erythrophobia, Hyper-hidrosis and Voice Paralysis: Berent has compiled a unique library of clinical interviews offering first-hand treatment accounts from successful patients: http://www.social-anxiety.com/clinical-interviews GREAT NECK, N.Y. (PRWEB) January 15, 2019 Jonathan Berent, L.C.S.W., pioneering therapist and author, offers a new...

Technique Identifies Electricity-producing Bacteria

NewsMicrobes screened with a new microfluidic process might be used in power generation or environmental cleanup.Contributed Author: 

Contagion® Announces 2019 Section Editors

Contagion®, the nation’s leading digital and print resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in the field of infectious diseases, announces the appointment of its 2019 section editors for the print publication. These medical professionals will work alongside the editorial staff ...

New JAMA Report, Initiated by AAAAI and Others, Provides Recommendations for Evaluating and Managing Penicillin Allergy

Verifying the accuracy of a documented penicillin allergy can improve treatment outcomes, avoid spread of antibiotic resistance MILWAUKEE (PRWEB) January 15, 2019 While more than 32 million individuals in the United States have a documented penicillin allergy in their medical record, studies have shown that over 95% can actually be treated safely with this class of antibiotics, improving treatmen...

Herbalife Nutrition Hosts 6th Annual Nutrition Industry Scientific Summit

Herbalife Nutrition Unveils Botanical DNA Field Testing Device and Methods at Summit Herbalife Nutrition (NYSE: HLF), a premier global nutrition company whose purpose is to make the world healthier and happier, today hosted the 6th annual nutrition industry scientific summit, in Torrance, California. At the summit, industry experts and those from ...

Strategies Needed for Resistance to Targeted Agents in HER2+ Breast Cancer

Mothaffar F. Rimawi, MD, discusses the current options in HER2-positive breast cancer and sheds light on where future research is headed.

Computer simulations reveal personalized treatment benefits kidney cancer patients

For early-stage kidney cancer patients who may be at risk for worsening kidney disease, personalized treatment plans such as undergoing active surveillance and MRI examinations may extend life expectancy, according to new research published Jan. 15 in Radiology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks